On the Helsinki Stock Exchange, prices rose in the wake of the rest of the world on Thursday, when the general index finally ended with a plus of 0.75 per cent to 12,837.18 points.
The hardest climbers of the day were Etteplan (+ 6.1%) and Nexttim (+ 4.5%). The steepest slips Questions (-12.5%) and Musti Group (-5,5 %).
Of the most traded shares, the best companies were forest companies Stora Enso (+3.5%) and UPM-Kymmene (+ 2.6%). Of the top ten, the least successful Nokia (-0,3 %).
Investment company Titanium (+ 4.0%) updated their medium-term objectives. The company aims to have a turnover of more than EUR 30 million for 2024. It also aims to maintain an average operating profit margin of more than 50 percent without amortization of goodwill. The company maintained its dividend policy.
Investors House (+3.2%) increased after announcing their dividend payment schedule. A dividend of 0.13 per share will be removed tomorrow. The record date is Monday, November 15th, and the payment date is November 22nd.
The earners were disappointed
Investors were disappointed with both earnings announcers as well as the plastics company Orthexin (-0.6%) that the mining company Endominesin (-3.4%) prices fell.
Orthex’s earnings report was characterized by declining profitability due to higher raw material prices. Endomines, on the other hand, will restart its mines in Finland and the United States, but net sales will remain low and losses high.
As early as Wednesday night, Endomines said it had finally found a new CEO. Pesti has been vacant since 2019, with three temporary CEOs in between.
At the moment Nordkalkin working as the Executive Vice President Kari Vyhtinen is due to take up the post in March 2022.
Tomorrow will report their results Fortum, Kamux and Remedy Entertainment.
The oil purifier announced its intentions to list
Again, the identity of the new company planning to go public was revealed when it specialized in natural cleansing and environmental solutions Lamor said it was aiming for the First North Premier marketplace on the Helsinki Stock Exchange.
So far, the only Finnish company listed on the Premier department has been shrinking drug particles Nanoform.
Lamor’s growth has been tremendous. At the end of September, its order backlog was EUR 228 million, compared to only EUR 24 million a year earlier. For next year, it will have an order backlog of approximately EUR 76 million.
In January-September 2021, the company made an adjusted EBITDA of EUR 4.7 million and an operating profit of EUR 1.4 million with a turnover of EUR 35.2 million.
Source: Arvopaperi by www.arvopaperi.fi.
*The article has been translated based on the content of Arvopaperi by www.arvopaperi.fi. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!